Education
About Us
Working with TipRanks
Follow Us
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | $ 0.00 | $ 50.00M | $ 0.00 | $ 0.00 |
| Gross Profit | $ -258.00K | $ 50.00M | $ -329.00K | $ 0.00 |
| Operating Income | $ -50.89M | $ -16.08M | $ -22.72M | $ -28.65M |
| EBITDA | $ -42.00M | $ 23.57M | $ -23.54M | $ -28.34M |
| Net Income | $ -42.26M | $ 22.72M | $ -24.25M | $ -29.00M |
| Balance Sheet | ||||
| Cash & Short-Term Investments | $ 204.76M | $ 125.19M | $ 47.24M | $ 69.00M |
| Total Assets | $ 212.85M | $ 130.39M | $ 50.64M | $ 70.52M |
| Total Debt | $ 6.26M | $ 193.19M | $ 5.85M | $ 4.91M |
| Net Debt | $ -15.68M | $ 177.67M | $ 280.00K | $ 279.00K |
| Total Liabilities | $ 14.78M | $ 198.32M | $ 11.37M | $ 8.93M |
| Stockholders' Equity | $ 198.07M | $ -67.94M | $ 39.27M | $ 61.59M |
| Cash Flow | ||||
| Free Cash Flow | $ -33.36M | $ 18.93M | $ -20.24M | $ -26.43M |
| Operating Cash Flow | $ -32.84M | $ 19.35M | $ -20.12M | $ -26.27M |
| Investing Cash Flow | $ -69.74M | $ -65.57M | $ 22.30M | $ -64.97M |
| Financing Cash Flow | $ 109.00M | $ 56.18M | $ -1.24M | $ 79.84M |